Japan Society of Clinical Trials and Research ( JPT Supplement )
Vol. 38 Suppl. 1 2010
【Japan Society of Clinical Trials and Research】
■ SYMPOSIUM
【Symposium 1:Progress in PGx】
Development of diagnostic kit for UGT1A1 gene
A. Mori, et al.
Jpn Pharmacol Ther 2010 38(s1) s16-9
Design of phase I trial for individualized dose level based on UGT1A1 testing
N. Ishizuka
Jpn Pharmacol Ther 2010 38(s1) s20-1
Tasks for generalizing PGx-based pharmacotherapy
Y. Uyama
Jpn Pharmacol Ther 2010 38(s1) s22-5
Points to consider of pharmacogenomics application in clinical trials (final draft)
T. Ichihara
Jpn Pharmacol Ther 2010 38(s1) s26-9
Prospect of PGx in new drug development
N. Kamatani
Jpn Pharmacol Ther 2010 38(s1) s30-2
PGx in clinical institution
H. Watanabe
Jpn Pharmacol Ther 2010 38(s1) s33-5
【Symposium2:How to improve support system for investigator initiated clinical trials?】
Clinical research service in the University of Tokyo Hospital
Y. Arakawa
Jpn Pharmacol Ther 2010 38(s1) s36-40
The current situation and challenges with management of clinical studies supported by Translational Research Informatics Center
K. Matsuyama, et al.
Jpn Pharmacol Ther 2010 38(s1) s41-5
From physician’s point of view of clinical data management
S. Hinotsu
Jpn Pharmacol Ther 2010 38(s1) s46-8
A approach from a biostatistician of clinical research
H.Ohtsu
Jpn Pharmacol Ther 2010 38(s1) s49-51
Coordinating protocol development in investigator initiated clinical trials
M. Niimi
Jpn Pharmacol Ther 2010 38(s1) s52-3
■ ORIGINAL ARTICLES
E. Aotani, et al.
Jpn Pharmacol Ther 2010 38(s1) s59-64